CD47 and ovarian cancer: The pSGNs were first conjugated to anti-human CD47 antibodies (hCD47-pSGNs); the conjugated pSGNs recognized CD47 molecules expressed on the surface of human ovarian cancer cells TOV21G but not on mouse ovarian cells ID8.